ENDOTHELIUM AND CARDIOVASCULAR DISEASES VASCULAR BIOLOGY AND CLINICAL SYNDROMES 2ED (PB 2025)

Endothelium and Cardiovascular Diseases: Vascular Biology and Clinical Syndromes, Second Edition offers new discoveries in clinical settings, cellular, molecular, genetic, and epigenetic mechanisms which have led to novel understanding of the key role of endothelium in both cardiovascular and non-cardiovascular diseases. The innovations it presents have implications for both pathophysiological concepts and clinical decisions. Among other topics, cardiovascular and pulmonary medicine, immunity and inflammation, genetics and epigenetics, heart failure, renal disease, familial hypercholesterolemia, diabetes, and hypertension are discussed at length.

With 20 new chapters covering everything from endothelium transition to connective tissue disorders, this second edition is sure to be indispensable to anyone wishing to learn the importance of endothelium to every facet of health.

• Examines the ways in which endothelium relates to almost every cardiovascular and systemic disease
• Provides a critical, in depth, pathophysiological review of endothelium which cannot be found in any other single volume
• Offers cutting-edge, critical knowledge for investigators and practitioners alike, information which has evolved rapidly since the previous edition

Professor Protásio L. da Luz, MD, FACC received his medical degree and completed a Residency and Specialization in Cardiology at Universidade de São Paulo Brazil (USP), and completed a postgraduate Fellowship in Critical Care Medicine at the University of Southern California. He has been a Research Scientist at Cedars-Sinai Medical Center, Full Professor of Cardiology at the Heart Institute (InCor) School of Medicine, USP, and Director of the InCor’s Cardiology Division and Atherosclerosis Unit. He is a Full Member of the Brazilian Academy of Sciences, Academy of Sciences of the State of São Paulo, and has authored or co-authored over 490 scientific publications and book chapters (258 of them peer-reviewed). Primary research interests include endothelium, atherosclerosis, coronary artery disease and prevention, and translational medicine. He received the Brazilian National Award for Scientific Merit, the Order of Medical Merit from the Brazilian government, and the Fundação Conrado Wessel Award in Medicine.

Dr. Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital and Mallinckrodt Professor of Medicine at Harvard Medical School (HMS). Receiving his medical degree from the University of California, San Diego School of Medicine, he undertook a cellular physiology research fellowship at HMS. After a residency in internal medicine and a fellowship in cardiovascular disease, he became board certified in both. He is an editor of the leading cardiovascular medicine textbook, and the author of over 500 peer-reviewed publications, 575 reviews, chapters, etc. He has received funding from the American Heart Association (AHA) and National Institutes of Health, plus recognitions on four continents, including the AHA and American College of Cardiology’s highest research awards, the Gold Medal of the European Society of Cardiology, the Anitschkow award from the European Atherosclerosis Society, the Ernst Jung Gold Medal for Medicine, and the Earl Benditt award for vascular biology.

Antonio Carlos Palandri Chagas MD, PhD, is Professor of Medicine and Chief of Cardiology at the Medical School of ABC, São Paulo Brazil, where he earned his medical degree. His Residency in Internal Medicine and postgraduate work in cardiology were at the University of São Paulo; his PhD thesis covered myocardial ischemia. His postdoctoral fellowship was at the University of California San Francisco’s Cardiovascular Research Institute. A Fellow of the American College of Cardiology (ACC) who serves on the board of the JACC, he was the Brazilian Chapter’s first governor. He belongs to the European Society of Cardiology. He was president of the São Paulo State Society of Cardiology, and the Brazilian Society of Cardiology. He attained ACC’s International Service Award; Chief of the Department of Internal Medicine at the Medical School of ABC; and Chair of ACC’s International Assembly of Governors. He has authored over 145 peer-reviewed journal publications.

Professor Francisco Rafael Martins Laurindo, MD received his medical degree and completed his Internal Medicine and Cardiology residency at the Heart Institute at the University of São Paulo School of Medicine in Brazil (FMUSP), where he earned his PhD on signaling processes in the vascular system. He trained in Physiology and Pharmacology at the University of Health Sciences, Bethesda, Maryland. He founded and has directed the Vascular Biology Laboratory at the Heart Institute (InCor), FMUSP since 2008. He is author or co-author of over 145 publications in peer-reviewed journals. He is a member of the Board of Directors of the Brazilian Academy of Sciences and a past Council Member of the Society for Free Radical Biology. He belongs to the Editorial Boards of Free Radical Biology and Medicine and Clinical Science, and served as Chair and Vice-Chair of the Gordon Research Conference on Nox Family NADPH Oxidases.